KCM
ANTH

Kennedy Capital Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Kennedy Capital Management’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,893
Closed -$150K – 776
2014
Q4 		$150K Sell
11,893
-8
-0.1% -$116 ﹤0.01% 733
2014
Q3 		$183K Sell
11,901
-182
-2% -$3.83K ﹤0.01% 758
2014
Q2 		$328K Buy
12,083
+112
+0.9% +$2.76K 0.01% 720
2014
Q1 		$321K Sell
11,971
-327
-3% -$8.3K 0.01% 717
2013
Q4 		$302K Buy
+12,298
New +$317K 0.01% 711

Other funds holding ANTH

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Kennedy Capital Management's ANTH Position: Q1 2015 in Review

Kennedy Capital Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2015, closing a stake of 11,893 shares — an estimated $150K sold.

Kennedy Capital Management first reported a position in ANTH in Q4 2013 and held it in 5 quarters. The position peaked at $328K in Q2 2014. 43 funds tracked by Wall St. Rank hold ANTH as of Q1 2015.

  • Kennedy Capital Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Kennedy Capital Management sold 11,893 Anthera Pharmaceuticals, Inc. shares in Q1 2015, an estimated $150K.
  • Kennedy Capital Management first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2013 and held it in 5 quarters.
  • Kennedy Capital Management's Anthera Pharmaceuticals, Inc. position peaked at $328K in Q2 2014.
  • 43 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2015.

Based on Kennedy Capital Management's 13F filing for Q1 2015, filed 7 May 2015.